Ajanta Pharma Limited Return on Equity (ROE) for the year ending March 31, 2025: 24.28%

Ajanta Pharma Limited Return on Equity (ROE) is 24.28% for the year ending March 31, 2025, a 6.14% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Ajanta Pharma Limited Return on Equity (ROE) for the year ending March 31, 2024 was 22.88%, a 31.83% change year over year.
  • Ajanta Pharma Limited Return on Equity (ROE) for the year ending March 31, 2023 was 17.35%, a -20.51% change year over year.
  • Ajanta Pharma Limited Return on Equity (ROE) for the year ending March 31, 2022 was 21.83%, a 0.02% change year over year.
  • Ajanta Pharma Limited Return on Equity (ROE) for the year ending March 31, 2021 was 21.83%, a 21.29% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share